241 related articles for article (PubMed ID: 10899873)
1. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.
Hou L; Sasaki H; Stashenko P
Infect Immun; 2000 Aug; 68(8):4681-7. PubMed ID: 10899873
[TBL] [Abstract][Full Text] [Related]
2. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance.
O'Brien GC; Wang JH; Redmond HP
J Immunol; 2005 Jan; 174(2):1020-6. PubMed ID: 15634926
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteria.
Rescigno M; Urbano M; Rimoldi M; Valzasina B; Rotta G; Granucci F; Ricciardi-Castagnoli P
Eur J Immunol; 2002 Oct; 32(10):2800-6. PubMed ID: 12355432
[TBL] [Abstract][Full Text] [Related]
4. Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice.
Kawashima N; Niederman R; Hynes RO; Ullmann-Cullere M; Stashenko P
Immunology; 1999 May; 97(1):117-23. PubMed ID: 10447722
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.
Abel B; Thieblemont N; Quesniaux VJ; Brown N; Mpagi J; Miyake K; Bihl F; Ryffel B
J Immunol; 2002 Sep; 169(6):3155-62. PubMed ID: 12218133
[TBL] [Abstract][Full Text] [Related]
6. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4.
Supajatura V; Ushio H; Nakao A; Okumura K; Ra C; Ogawa H
J Immunol; 2001 Aug; 167(4):2250-6. PubMed ID: 11490012
[TBL] [Abstract][Full Text] [Related]
7. Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.
Okamoto M; Oshikawa T; Ohe G; Nishikawa H; Furuichi S; Tano T; Moriya Y; Saito M; Sato M
Int Immunopharmacol; 2001 Sep; 1(9-10):1789-95. PubMed ID: 11562070
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 deficiency increases inflammatory bone destruction.
Balto K; Sasaki H; Stashenko P
Infect Immun; 2001 Feb; 69(2):744-50. PubMed ID: 11159963
[TBL] [Abstract][Full Text] [Related]
9. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages.
Itoh K; Udagawa N; Kobayashi K; Suda K; Li X; Takami M; Okahashi N; Nishihara T; Takahashi N
J Immunol; 2003 Apr; 170(7):3688-95. PubMed ID: 12646634
[TBL] [Abstract][Full Text] [Related]
11. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages.
Matsuguchi T; Musikacharoen T; Ogawa T; Yoshikai Y
J Immunol; 2000 Nov; 165(10):5767-72. PubMed ID: 11067935
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
Hoshino K; Takeuchi O; Kawai T; Sanjo H; Ogawa T; Takeda Y; Takeda K; Akira S
J Immunol; 1999 Apr; 162(7):3749-52. PubMed ID: 10201887
[TBL] [Abstract][Full Text] [Related]
13. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M
Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725
[TBL] [Abstract][Full Text] [Related]
14. Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.
Netea MG; Kullberg BJ; Galama JM; Stalenhoef AF; Dinarello CA; Van der Meer JW
Eur J Immunol; 2002 Apr; 32(4):1188-95. PubMed ID: 11932927
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis.
Kamath AB; Alt J; Debbabi H; Behar SM
Infect Immun; 2003 Jul; 71(7):4112-8. PubMed ID: 12819102
[TBL] [Abstract][Full Text] [Related]
16. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
Li N; Klaassen CD
Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
[TBL] [Abstract][Full Text] [Related]
18. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.
Campos MA; Rosinha GM; Almeida IC; Salgueiro XS; Jarvis BW; Splitter GA; Qureshi N; Bruna-Romero O; Gazzinelli RT; Oliveira SC
Infect Immun; 2004 Jan; 72(1):176-86. PubMed ID: 14688095
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 signaling regulates the acute local inflammatory response to injury and the fibrosis/neovascularization of sterile wounds.
Brancato SK; Thomay AA; Daley JM; Crane MJ; Reichner JS; Sabo E; Albina JE
Wound Repair Regen; 2013; 21(4):624-633. PubMed ID: 23758142
[TBL] [Abstract][Full Text] [Related]
20. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Poltorak A; He X; Smirnova I; Liu MY; Van Huffel C; Du X; Birdwell D; Alejos E; Silva M; Galanos C; Freudenberg M; Ricciardi-Castagnoli P; Layton B; Beutler B
Science; 1998 Dec; 282(5396):2085-8. PubMed ID: 9851930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
